nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenylpyraline—SLC6A3—Parkinson's disease	0.835	1	CbGaD
Diphenylpyraline—SLC6A3—Dopaminergic Neurogenesis—PITX3—Parkinson's disease	0.00707	0.0519	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Clearance of dopamine—COMT—Parkinson's disease	0.00575	0.0422	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Clearance of dopamine—MAOA—Parkinson's disease	0.0057	0.0419	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Dopaminergic Neurogenesis—LMX1A—Parkinson's disease	0.00536	0.0393	CbGpPWpGaD
Diphenylpyraline—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00535	0.243	CbGeAlD
Diphenylpyraline—SLC6A3—Alpha-synuclein signaling—SNCAIP—Parkinson's disease	0.00444	0.0326	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—SEPT5—Parkinson's disease	0.00444	0.0326	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—PINK1—Parkinson's disease	0.00444	0.0326	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Dopaminergic Neurogenesis—EN1—Parkinson's disease	0.00406	0.0298	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—SNCAIP—Parkinson's disease	0.00377	0.0277	CbGpPWpGaD
Diphenylpyraline—SLC6A3—nerve—Parkinson's disease	0.00337	0.153	CbGeAlD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—HTRA2—Parkinson's disease	0.00336	0.0247	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—ATXN2—Parkinson's disease	0.00286	0.021	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—Parkinson's disease	0.00262	0.0192	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Dopaminergic Neurogenesis—NR4A2—Parkinson's disease	0.00262	0.0192	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—Parkinson's disease	0.0026	0.0191	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Alpha-synuclein signaling—PARK7—Parkinson's disease	0.00255	0.0187	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—GPR37—Parkinson's disease	0.00255	0.0187	CbGpPWpGaD
Diphenylpyraline—SLC6A3—hindbrain—Parkinson's disease	0.00253	0.115	CbGeAlD
Diphenylpyraline—SLC6A3—Monoamine Transport—DBH—Parkinson's disease	0.00249	0.0182	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC18A2—Parkinson's disease	0.00235	0.0173	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Alpha-synuclein signaling—UCHL1—Parkinson's disease	0.00233	0.0171	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Alpha-synuclein signaling—GRK5—Parkinson's disease	0.00227	0.0167	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—PARK7—Parkinson's disease	0.00217	0.0159	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Alpha-synuclein signaling—SNCA—Parkinson's disease	0.00204	0.015	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—UCHL1—Parkinson's disease	0.00198	0.0145	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—LRRK2—Parkinson's disease	0.00193	0.0142	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Dopaminergic Neurogenesis—DDC—Parkinson's disease	0.00192	0.0141	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—SNCA—Parkinson's disease	0.00173	0.0127	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Dopaminergic Neurogenesis—SLC18A2—Parkinson's disease	0.00163	0.012	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Amine compound SLC transporters—SLC18A2—Parkinson's disease	0.00163	0.012	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—DDC—Parkinson's disease	0.00159	0.0117	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Alpha-synuclein signaling—MAOB—Parkinson's disease	0.00157	0.0116	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Alpha-synuclein signaling—PARK2—Parkinson's disease	0.00145	0.0107	CbGpPWpGaD
Diphenylpyraline—SLC6A3—brainstem—Parkinson's disease	0.00145	0.0659	CbGeAlD
Diphenylpyraline—SLC6A3—forebrain—Parkinson's disease	0.0014	0.0636	CbGeAlD
Diphenylpyraline—SLC6A3—Monoamine Transport—ADORA2A—Parkinson's disease	0.00136	0.01	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—PARK2—Parkinson's disease	0.00123	0.00906	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Dopaminergic Neurogenesis—TH—Parkinson's disease	0.00107	0.00786	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Alpha-synuclein signaling—TH—Parkinson's disease	0.00104	0.00766	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Monoamine Transport—TH—Parkinson's disease	0.00102	0.00747	CbGpPWpGaD
Diphenylpyraline—Ifenprodil—GRIN2B—Parkinson's disease	0.000942	0.134	CrCbGaD
Diphenylpyraline—SLC6A3—midbrain—Parkinson's disease	0.000923	0.042	CbGeAlD
Diphenylpyraline—HRH1—Monoamine GPCRs—HTR1A—Parkinson's disease	0.000909	0.00667	CbGpPWpGaD
Diphenylpyraline—SLC6A3—spinal cord—Parkinson's disease	0.0009	0.041	CbGeAlD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—TH—Parkinson's disease	0.000886	0.00651	CbGpPWpGaD
Diphenylpyraline—HRH1—Monoamine GPCRs—DRD1—Parkinson's disease	0.000878	0.00644	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—CYCS—Parkinson's disease	0.000851	0.00625	CbGpPWpGaD
Diphenylpyraline—HRH1—Monoamine GPCRs—DRD3—Parkinson's disease	0.00085	0.00624	CbGpPWpGaD
Diphenylpyraline—HRH1—forebrain—Parkinson's disease	0.000811	0.0369	CbGeAlD
Diphenylpyraline—SLC6A3—head—Parkinson's disease	0.0008	0.0364	CbGeAlD
Diphenylpyraline—HRH1—Monoamine GPCRs—HTR7—Parkinson's disease	0.000769	0.00564	CbGpPWpGaD
Diphenylpyraline—HRH1—Monoamine GPCRs—DRD2—Parkinson's disease	0.000769	0.00564	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—HCN3—Parkinson's disease	0.000765	0.00562	CbGpPWpGaD
Diphenylpyraline—HRH1—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.000764	0.00561	CbGpPWpGaD
Diphenylpyraline—SLC6A3—nervous system—Parkinson's disease	0.000758	0.0345	CbGeAlD
Diphenylpyraline—HRH1—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.000738	0.00542	CbGpPWpGaD
Diphenylpyraline—SLC6A3—central nervous system—Parkinson's disease	0.00073	0.0332	CbGeAlD
Diphenylpyraline—HRH1—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.000715	0.00525	CbGpPWpGaD
Diphenylpyraline—SLC6A3—cerebellum—Parkinson's disease	0.000714	0.0325	CbGeAlD
Diphenylpyraline—HRH1—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.000646	0.00474	CbGpPWpGaD
Diphenylpyraline—HRH1—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.000646	0.00474	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.000644	0.00472	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.000639	0.00469	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.000588	0.00431	CbGpPWpGaD
Diphenylpyraline—SLC6A3—brain—Parkinson's disease	0.00058	0.0264	CbGeAlD
Diphenylpyraline—HRH1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.000561	0.00412	CbGpPWpGaD
Diphenylpyraline—Benzphetamine—SLC18A2—Parkinson's disease	0.000558	0.0795	CrCbGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.000556	0.00408	CbGpPWpGaD
Diphenylpyraline—HRH1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.000538	0.00395	CbGpPWpGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—GSTA4—Parkinson's disease	0.000511	0.00375	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.000502	0.00369	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—KCNJ4—Parkinson's disease	0.000493	0.00362	CbGpPWpGaD
Diphenylpyraline—HRH1—head—Parkinson's disease	0.000464	0.0211	CbGeAlD
Diphenylpyraline—HRH1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.000453	0.00332	CbGpPWpGaD
Diphenylpyraline—HRH1—nervous system—Parkinson's disease	0.00044	0.02	CbGeAlD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000435	0.00319	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000434	0.00318	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—DLG1—Parkinson's disease	0.000426	0.00312	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.000425	0.00312	CbGpPWpGaD
Diphenylpyraline—HRH1—central nervous system—Parkinson's disease	0.000424	0.0193	CbGeAlD
Diphenylpyraline—SLC6A3—Monoamine Transport—IL1B—Parkinson's disease	0.000415	0.00305	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.00038	0.00279	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000372	0.00273	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00037	0.00271	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Parkinsons Disease Pathway—CASP3—Parkinson's disease	0.000361	0.00265	CbGpPWpGaD
Diphenylpyraline—Benzatropine—SLC6A3—Parkinson's disease	0.000361	0.0514	CrCbGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000358	0.00263	CbGpPWpGaD
Diphenylpyraline—HRH1—brain—Parkinson's disease	0.000337	0.0153	CbGeAlD
Diphenylpyraline—SLC6A3—Neuronal System—GRIK1—Parkinson's disease	0.000333	0.00245	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.000308	0.00226	CbGpPWpGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—NQO1—Parkinson's disease	0.000306	0.00225	CbGpPWpGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—HSPA1A—Parkinson's disease	0.000304	0.00223	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Monoamine Transport—TNF—Parkinson's disease	0.000301	0.00221	CbGpPWpGaD
Diphenylpyraline—Reboxetine—CYP2D6—Parkinson's disease	0.0003	0.0427	CrCbGaD
Diphenylpyraline—Trospium—CYP2D6—Parkinson's disease	0.000294	0.0419	CrCbGaD
Diphenylpyraline—Bifonazole—CYP2E1—Parkinson's disease	0.000291	0.0414	CrCbGaD
Diphenylpyraline—SLC6A3—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00029	0.00213	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000283	0.00208	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—GRIK2—Parkinson's disease	0.000283	0.00208	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—GPR37—Parkinson's disease	0.000283	0.00208	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000278	0.00204	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000278	0.00204	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.000275	0.00202	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—SLC18A2—Parkinson's disease	0.000274	0.00201	CbGpPWpGaD
Diphenylpyraline—SLC6A3—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000267	0.00196	CbGpPWpGaD
Diphenylpyraline—Modafinil—SLC6A3—Parkinson's disease	0.000267	0.038	CrCbGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00026	0.00191	CbGpPWpGaD
Diphenylpyraline—Cyproheptadine—HTR1A—Parkinson's disease	0.000259	0.037	CrCbGaD
Diphenylpyraline—Mianserin—HTR7—Parkinson's disease	0.000257	0.0366	CrCbGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—GSTP1—Parkinson's disease	0.000256	0.00188	CbGpPWpGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—HMOX1—Parkinson's disease	0.000252	0.00185	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000244	0.00179	CbGpPWpGaD
Diphenylpyraline—Mianserin—DRD3—Parkinson's disease	0.000241	0.0344	CrCbGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00024	0.00176	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000238	0.00175	CbGpPWpGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—GSTM1—Parkinson's disease	0.000235	0.00172	CbGpPWpGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—HGF—Parkinson's disease	0.000235	0.00172	CbGpPWpGaD
Diphenylpyraline—Benzphetamine—SLC6A3—Parkinson's disease	0.000231	0.033	CrCbGaD
Diphenylpyraline—Atomoxetine—SLC6A3—Parkinson's disease	0.00023	0.0327	CrCbGaD
Diphenylpyraline—Mianserin—SLC6A3—Parkinson's disease	0.000224	0.032	CrCbGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.000223	0.00164	CbGpPWpGaD
Diphenylpyraline—Cyproheptadine—DRD2—Parkinson's disease	0.00022	0.0314	CrCbGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000219	0.00161	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—CHRNA4—Parkinson's disease	0.000217	0.00159	CbGpPWpGaD
Diphenylpyraline—Reboxetine—ABCB1—Parkinson's disease	0.000214	0.0305	CrCbGaD
Diphenylpyraline—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000202	0.00148	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.0002	0.00147	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.0002	0.00147	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—HSPA8—Parkinson's disease	0.000199	0.00146	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000198	0.00145	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.000198	0.00145	CbGpPWpGaD
Diphenylpyraline—Mianserin—HTR1A—Parkinson's disease	0.000197	0.028	CrCbGaD
Diphenylpyraline—HRH1—GPCR ligand binding—GRM4—Parkinson's disease	0.000192	0.00141	CbGpPWpGaD
Diphenylpyraline—Cinnarizine—DRD2—Parkinson's disease	0.000192	0.0274	CrCbGaD
Diphenylpyraline—Benzatropine—CYP2D6—Parkinson's disease	0.00019	0.027	CrCbGaD
Diphenylpyraline—SLC6A3—Neuronal System—DLG4—Parkinson's disease	0.000187	0.00137	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—GRIN2B—Parkinson's disease	0.000183	0.00134	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—PENK—Parkinson's disease	0.000182	0.00134	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.000177	0.0013	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000175	0.00129	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000173	0.00127	CbGpPWpGaD
Diphenylpyraline—Cyproheptadine—HTR2A—Parkinson's disease	0.00017	0.0243	CrCbGaD
Diphenylpyraline—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000169	0.00124	CbGpPWpGaD
Diphenylpyraline—Mianserin—DRD2—Parkinson's disease	0.000167	0.0238	CrCbGaD
Diphenylpyraline—HRH1—GPCR ligand binding—PDYN—Parkinson's disease	0.000167	0.00122	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000164	0.0012	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00016	0.00117	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—GRM5—Parkinson's disease	0.000155	0.00114	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.000154	0.00113	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—COMT—Parkinson's disease	0.000153	0.00112	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—MAOA—Parkinson's disease	0.000152	0.00111	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00015	0.0011	CbGpPWpGaD
Diphenylpyraline—Bepridil—CYP2D6—Parkinson's disease	0.000149	0.0213	CrCbGaD
Diphenylpyraline—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000148	0.00109	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000148	0.00109	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000148	0.00109	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000147	0.00108	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GPR37—Parkinson's disease	0.000145	0.00107	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—DGKQ—Parkinson's disease	0.000145	0.00107	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000145	0.00107	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000141	0.00103	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.000137	0.00101	CbGpPWpGaD
Diphenylpyraline—Cinnarizine—CYP2D6—Parkinson's disease	0.000136	0.0193	CrCbGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000136	0.000996	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.000134	0.000987	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000133	0.000975	CbGpPWpGaD
Diphenylpyraline—Atomoxetine—HTR2A—Parkinson's disease	0.000132	0.0188	CrCbGaD
Diphenylpyraline—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000132	0.000968	CbGpPWpGaD
Diphenylpyraline—Mianserin—HTR2A—Parkinson's disease	0.000129	0.0184	CrCbGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000127	0.000933	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000127	0.000933	CbGpPWpGaD
Diphenylpyraline—Orphenadrine—CYP2E1—Parkinson's disease	0.000126	0.0179	CrCbGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000121	0.00089	CbGpPWpGaD
Diphenylpyraline—Atomoxetine—CYP2D6—Parkinson's disease	0.000121	0.0172	CrCbGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00012	0.000883	CbGpPWpGaD
Diphenylpyraline—Mianserin—CYP2D6—Parkinson's disease	0.000118	0.0168	CrCbGaD
Diphenylpyraline—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000114	0.00084	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	0.000113	0.000827	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	0.000111	0.000811	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	0.00011	0.000808	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000109	0.000798	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	0.000107	0.000786	CbGpPWpGaD
Diphenylpyraline—Bepridil—ABCB1—Parkinson's disease	0.000107	0.0152	CrCbGaD
Diphenylpyraline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000104	0.000763	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—VPS35—Parkinson's disease	0.000104	0.00076	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	0.000103	0.000757	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000102	0.000747	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	9.87e-05	0.000725	CbGpPWpGaD
Diphenylpyraline—Fentanyl—ABCB1—Parkinson's disease	9.8e-05	0.014	CrCbGaD
Diphenylpyraline—Diphenhydramine—CYP2D6—Parkinson's disease	9.75e-05	0.0139	CrCbGaD
Diphenylpyraline—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	9.68e-05	0.000711	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	9.68e-05	0.000711	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	9.43e-05	0.000692	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PENK—Parkinson's disease	9.36e-05	0.000687	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.29e-05	0.000682	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	8.9e-05	0.000654	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	8.77e-05	0.000643	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	8.58e-05	0.00063	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GPR37—Parkinson's disease	8.58e-05	0.00063	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	8.56e-05	0.000628	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.07e-05	0.000592	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	7.96e-05	0.000584	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	7.85e-05	0.000576	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	7.75e-05	0.000569	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.75e-05	0.000569	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	7.45e-05	0.000547	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—RIT2—Parkinson's disease	6.86e-05	0.000504	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	6.78e-05	0.000498	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	6.77e-05	0.000497	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRK5—Parkinson's disease	6.5e-05	0.000477	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	6.47e-05	0.000475	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	6.37e-05	0.000467	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	6.25e-05	0.000458	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	6.05e-05	0.000444	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	5.87e-05	0.000431	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRM4—Parkinson's disease	5.83e-05	0.000428	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	5.78e-05	0.000425	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	5.67e-05	0.000416	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.65e-05	0.000415	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MAG—Parkinson's disease	5.53e-05	0.000406	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PENK—Parkinson's disease	5.53e-05	0.000406	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	5.49e-05	0.000403	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	5.47e-05	0.000402	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	5.47e-05	0.000402	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	5.13e-05	0.000377	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PDYN—Parkinson's disease	5.06e-05	0.000371	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	4.97e-05	0.000365	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	4.97e-05	0.000365	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GFAP—Parkinson's disease	4.76e-05	0.000349	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRM5—Parkinson's disease	4.7e-05	0.000345	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	4.38e-05	0.000321	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.17e-05	0.000306	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGF20—Parkinson's disease	4.12e-05	0.000303	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	4e-05	0.000293	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	3.98e-05	0.000292	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.83e-05	0.000281	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—INSR—Parkinson's disease	3.69e-05	0.000271	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGB—Parkinson's disease	3.49e-05	0.000256	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	3.48e-05	0.000255	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	3.47e-05	0.000255	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TAC1—Parkinson's disease	3.42e-05	0.000251	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—DRD1—Parkinson's disease	3.35e-05	0.000246	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—DRD3—Parkinson's disease	3.24e-05	0.000238	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	3.03e-05	0.000222	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HTR7—Parkinson's disease	2.93e-05	0.000215	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—DRD2—Parkinson's disease	2.93e-05	0.000215	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IGF2—Parkinson's disease	2.46e-05	0.000181	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	2.38e-05	0.000175	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—EDN1—Parkinson's disease	2.35e-05	0.000172	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NGF—Parkinson's disease	2.16e-05	0.000158	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	2.06e-05	0.000151	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—APOE—Parkinson's disease	1.91e-05	0.00014	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—INS—Parkinson's disease	1.63e-05	0.00012	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CASP3—Parkinson's disease	1.22e-05	8.92e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—IL6—Parkinson's disease	1.21e-05	8.86e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	1.12e-05	8.2e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IL6—Parkinson's disease	7.13e-06	5.24e-05	CbGpPWpGaD
